Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PPR18 | Q6NYC8 | Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18) | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| PRAME | P78395 | Melanoma antigen preferentially expressed in tumors (Opa-interacting protein 4) (OIP-4) (Preferentially expressed antigen of melanoma) | Plasma proteinsPredicted intracellular proteins | Malignant haematopoietic neoplasmSolid tumour/cancer | Clinical-translation mediation | 1 | 0.38 | |||
| PRR32 | B1ATL7 | Proline-rich protein 32 | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| PRS8 | P62195 | 26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG) | Essential proteinsPlasma proteinsPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| PRSR2 | Q86WR7 | Proline and serine-rich protein 2 | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| PTN13 | Q12923 | Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1) | Cancer-related genesEnzymesPredicted intracellular proteins | Immune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| PTPRK | Q15262 | Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) | Cancer-related genesEnzymesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.38 | |||
| PTPRR | Q15256 | Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1) | EnzymesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Metabolism mediationReceptor-signaling mediation | 1 | 0.38 | |||
| PVR | P15151 | Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155) | CD markersPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.38 | |||
| PXDC1 | Q5TGL8 | PX domain-containing protein 1 | Other mediation | 1 | 0.38 | |||||
| R4RL1 | Q86UN2 | Reticulon-4 receptor-like 1 (Nogo receptor-like 2) (Nogo-66 receptor homolog 2) (Nogo-66 receptor-related protein 3) (NgR3) | Predicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 1 | 0.38 | ||||
| RAI2 | Q9Y5P3 | Retinoic acid-induced protein 2 | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| RAI3 | Q8NFJ5 | Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1) | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteins | 7 | Receptor-signaling mediation | 1 | 0.38 | |||
| RASD1 | Q9Y272 | Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1) | Human disease related genesPredicted intracellular proteins | Receptor-signaling mediation | 1 | 0.38 | ||||
| RASL1 | O95294 | RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) | Plasma proteinsPredicted intracellular proteinsRAS pathway related proteins | Receptor-signaling mediation | 1 | 0.38 | ||||
| RCCD1 | A6NED2 | RCC1 domain-containing protein 1 | Predicted intracellular proteins | Metabolism mediation | 1 | 0.38 | ||||
| REN3A | Q9H1J1 | Regulator of nonsense transcripts 3A (Nonsense mRNA reducing factor 3A) (Up-frameshift suppressor 3 homolog A) (hUpf3) | Predicted intracellular proteins | Other mediation | 1 | 0.38 | ||||
| RET | P07949 | Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] | Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Breast cancerColon cancerColorectal cancerIndeterminate colitisLung cancerMature B-cell lymphomaMultiple myelomaMyelodysplastic syndromeNeurodegenerative disorderSolid tumour/cancerThrombocytopeniaThyroid cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.38 | ||
| RGPA2 | Q2PPJ7 | Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220) | Predicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| RHG19 | Q14CB8 | Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19) | Predicted intracellular proteins | Receptor-signaling mediation | 1 | 0.38 | ||||
| RHG23 | Q9P227 | Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23) | Predicted intracellular proteins | Receptor-signaling mediation | 1 | 0.38 | ||||
| RHG24 | Q8N264 | Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP) | Predicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| RHG33 | O14559 | Rho GTPase-activating protein 33 (Rho-type GTPase-activating protein 33) (Sorting nexin-26) (Tc10/CDC42 GTPase-activating protein) | Predicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| RHG40 | Q5TG30 | Rho GTPase-activating protein 40 (Rho-type GTPase-activating protein 40) | Predicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.38 | ||||
| RHXF2 | Q9BQY4 | Rhox homeobox family member 2 (Paired-like homeobox protein PEPP-2) (Testis homeobox gene 1) | Predicted intracellular proteinsTranscription factors | Other mediation | 1 | 0.38 |